Raftery A, Pattaroni C, Harris N, Tsantikos E, Hibbs M
Inflamm Res. 2024; 73(12):2123-2139.
PMID: 39432107
PMC: 11632041.
DOI: 10.1007/s00011-024-01953-x.
Yin Z, Rosenzweig N, Kleemann K, Zhang X, Brandao W, Margeta M
Nat Immunol. 2023; 24(11):1839-1853.
PMID: 37749326
PMC: 10863749.
DOI: 10.1038/s41590-023-01627-6.
Samuels J, Moore K, Ennerfelt H, Johnson A, Walsh A, Price R
Alzheimers Dement. 2023; 19(11):4908-4921.
PMID: 37061460
PMC: 10576836.
DOI: 10.1002/alz.13089.
Fernandes S, Srivastava N, Pedicone C, Sudan R, Luke E, Dungan O
iScience. 2023; 26(2):106071.
PMID: 36818285
PMC: 9929608.
DOI: 10.1016/j.isci.2023.106071.
Castranio E, Hasel P, Haure-Mirande J, Ramirez Jimenez A, Hamilton B, Kim R
Alzheimers Dement. 2022; 19(6):2239-2252.
PMID: 36448627
PMC: 10481344.
DOI: 10.1002/alz.12821.
Characterization of an intelectin-1 () knockout mouse model.
Nonnecke E, Castillo P, Akahoshi D, Goley S, Bevins C, Lonnerdal B
Front Immunol. 2022; 13:894649.
PMID: 36072603
PMC: 9441953.
DOI: 10.3389/fimmu.2022.894649.
Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19.
Lu T, Ma R, Dong W, Teng K, Kollath D, Li Z
Nat Commun. 2022; 13(1):2576.
PMID: 35546150
PMC: 9095674.
DOI: 10.1038/s41467-022-30216-8.
Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity.
Xia M, Wang B, Wang Z, Zhang X, Wang X
Front Immunol. 2021; 12:672328.
PMID: 34017344
PMC: 8129532.
DOI: 10.3389/fimmu.2021.672328.
Selective deletion of SHIP-1 in hematopoietic cells in mice leads to severe lung inflammation involving ILC2 cells.
Ye X, Zhang F, Zhou L, Wei Y, Zhang L, Wang L
Sci Rep. 2021; 11(1):9220.
PMID: 33911168
PMC: 8080607.
DOI: 10.1038/s41598-021-88677-8.
Targeting SHIP1 and SHIP2 in Cancer.
Pedicone C, Meyer S, Chisholm J, Kerr W
Cancers (Basel). 2021; 13(4).
PMID: 33672717
PMC: 7924360.
DOI: 10.3390/cancers13040890.
Unraveling exhaustion in adaptive and conventional NK cells.
Merino A, Kim H, Miller J, Cichocki F
J Leukoc Biol. 2020; 108(4):1361-1368.
PMID: 32726880
PMC: 7722010.
DOI: 10.1002/JLB.4MR0620-091R.
SHIP-1, a target of miR-155, regulates endothelial cell responses in lung fibrosis.
Tang H, Mao J, Ye X, Zhang F, Kerr W, Zheng T
FASEB J. 2020; 34(2):2011-2023.
PMID: 31907997
PMC: 7449602.
DOI: 10.1096/fj.201902063R.
Human Papillomavirus Type 16 Disables the Increased Natural Killer Cells in Early Lesions of the Cervix.
Zhang J, Jin S, Li X, Liu L, Xi L, Wang F
J Immunol Res. 2019; 2019:9182979.
PMID: 31183395
PMC: 6512046.
DOI: 10.1155/2019/9182979.
Targeting SHIP-1 in Myeloid Cells Enhances Trained Immunity and Boosts Response to Infection.
Saz-Leal P, Del Fresno C, Brandi P, Martinez-Cano S, Dungan O, Chisholm J
Cell Rep. 2018; 25(5):1118-1126.
PMID: 30380404
PMC: 6226423.
DOI: 10.1016/j.celrep.2018.09.092.
SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn's Disease and Peripheral T Cell Reduction.
Fernandes S, Srivastava N, Sudan R, Middleton F, Shergill A, Ryan J
Front Immunol. 2018; 9:1100.
PMID: 29872435
PMC: 5972310.
DOI: 10.3389/fimmu.2018.01100.
Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides.
Elich M, Sauer K
Front Immunol. 2018; 9:931.
PMID: 29780388
PMC: 5945867.
DOI: 10.3389/fimmu.2018.00931.
Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor.
Bern M, Beckman D, Ebihara T, Taffner S, Poursine-Laurent J, White J
Proc Natl Acad Sci U S A. 2017; 114(40):E8440-E8447.
PMID: 28923946
PMC: 5635927.
DOI: 10.1073/pnas.1713064114.
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.
Liu E, Tong Y, Dotti G, Shaim H, Savoldo B, Mukherjee M
Leukemia. 2017; 32(2):520-531.
PMID: 28725044
PMC: 6063081.
DOI: 10.1038/leu.2017.226.
The Abl-1 Kinase is Dispensable for NK Cell Inhibitory Signalling and is not Involved in Murine NK Cell Education.
Ganesan S, Luu T, Chambers B, Meinke S, Brodin P, Vivier E
Scand J Immunol. 2017; 86(3):135-142.
PMID: 28605050
PMC: 5568956.
DOI: 10.1111/sji.12574.
A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome.
Srivastava N, Iyer S, Sudan R, Youngs C, Engelman R, Howard K
JCI Insight. 2016; 1(11).
PMID: 27536730
PMC: 4985248.
DOI: 10.1172/jci.insight.88544.